INTERNATIONAL PATENT: ARROWHEAD PHARMACEUTICALS, INC. FILES APPLICATION FOR "RNAI AGENTS FOR INHIBITING EXPRESSION OF HUNTINGTIN (HTT), COMPOSITIONS THEREOF AND METHODS OF USE"

GENEVA, Dec. 31 -- ARROWHEAD PHARMACEUTICALS, INC. (177 East Colorado Boulevard, Suite 700Pasadena, California 91105) filed a patent application (PCT/US2025/034524) for "RNAI AGENTS FOR INHIBITING EXPRESSION OF HUNTINGTIN (HTT), COMPOSITIONS THEREOF, AND METHODS OF USE" on Jun 20, 2025. With publication no. WO/2025/265013, the details related to the patent application was published on Dec 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ESAU, Christine (c/o Arrowhead Pharmaceuticals, INC.10102 Hoyt Park DriveSan Diego, California 92131), PEI, Tao (c/o Arrowhead Pharmaceuticals, INC.502 So...